Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin crossover trial in women with polycystic ovary syndrome
ACTRN12610000202066Phase 4Recruiting
- Sponsor
- Cardiology Unit
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Cardiology Unit. Primary endpoint: Platelet nitric oxide responsiveness. Started Mar 2010; status: recruiting.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ACTRN12610000202066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000202066.